Laird Norton Wetherby Trust Company, LLC
BankPosition in RPRX — Royalty Pharma plc
CIK 723204
Seattle, WA
Position in RPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$940,691
+$88,062 QoQ
Shares Held
19,610
-11.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0.7955124936257012.ToString("F0")%
Shared 0.ToString("F0")%
None 99.20448750637429.ToString("F0")%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Laird Norton Wetherby Trust Company, LLC holds $17,378,255 across 18 Biotechnology names. RPRX ranks #6 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,890 | $5,309,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,635 | $2,035,905 | |
| 3 | ARGX |
Argenx SE
|
2,114 | $1,543,747 | |
| 4 | ANIX |
Anixa Biosciences Inc
|
566,327 | $1,461,123 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,507 | $1,160,360 | |
| 6 | RPRX |
Royalty Pharma plc
This page
|
19,610 | $940,691 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
6,805 | $661,785 | |
| 8 | INCY |
Incyte Corp
|
6,944 | $653,569 |
All Filings in RPRX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $940,691 | 19,610 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $852,629 | 22,066 | Shares | Other | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||